AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch

Aeterna Zentaris Inc. has completed its phase III trial of Zoptrex in women with advanced, metastatic endometrial cancer.

from RTT - Biotech http://ift.tt/2kJR55k
via IFTTT